Uncategorized - Cancer Therapy Advisor

Ask the Experts

Chronic Lymphocytic Leukemia: New Treatment Approaches Highlighted at ASCO 2019

Cancer Therapy Advisor asked 3 experts in chronic lymphocytic leukemia to weigh in on minimal residual disease measurement, CAR-T therapies, genomic testing, and key data that were presented at the 2019 ASCO Annual Meeting. READ MORE »

Insights From the 2019 ASCO Annual Meeting: Breast Cancer

Cancer Therapy Advisor asked an expert to weigh in on what she thought were the most important data on breast cancer presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. READ MORE »

Translating ASCO Data Into Clinical Practice for Patients with Lymphoma

What is your strategy for communicating with patients about the general efficacy of drugs that exist to treat classical Hodgkin lymphoma? READ MORE »

Using Novel Anti-Androgens in Non-Metastatic CRPC

What should be the basis for starting non-metastatic CRPC patients on one of the novel anti-androgens? READ MORE »

Clinical Insights in Metastatic Breast Cancer

Cancer Therapy Advisor asked 3 experts to weigh in on the treatment of metastatic breast cancer. READ MORE »

Treating Patients with Nonsquamous Non-Small Cell Lung Cancer

Cancer Therapy Advisor asked 2 experts to weigh in on recommended treatment modalities. READ MORE »

Clinical Insights in Soft Tissue Sarcoma

Cancer Therapy Advisor asked 2 experts to weigh in on clinical insights in soft tissue sarcoma. READ MORE »

Translating ASCO Data Into Clinical Practice for Patients with Breast Cancer

Cancer Therapy Advisor asked 3 experts to weigh in on translating ASCO data into clinical practice for patients with breast cancer. READ MORE »

Decisions in the Clinic: Treating Patients With Waldenström Macroglobulinemia

Cancer Therapy Advisor asked 3 experts to weigh in on recommended treatment modalities for patients with Waldenström macroglobulinemia. READ MORE »

Novel Treatment Approaches in Multiple Myeloma

Cancer Therapy Advisor asked an expert to weigh in on novel treatment approaches in multiple myeloma discussed at the ASH 2018 meeting. READ MORE »

Novel Treatment Approaches in Chronic Lymphocytic Leukemia

Cancer Therapy Advisor asked an expert to weigh in on novel treatment approaches in chronic lymphocytic leukemia presented at the ASH 2018 meeting. READ MORE »